Exploring the causal relationship between inflammatory cytokines and inflammatory arthritis: A Mendelian randomization study

被引:11
|
作者
Pan, Shixin [1 ,2 ]
Wu, Shaofeng [1 ,2 ]
Wei, Yating [1 ,2 ]
Liu, Jingjing [3 ]
Zhou, Chenxing [1 ,2 ]
Chen, Tianyou [1 ,2 ]
Zhu, Jichong [1 ,2 ]
Tan, Weiming [1 ,2 ]
Huang, Chengqian [1 ,2 ]
Feng, Sitan [1 ,2 ]
Zhang, Bin [1 ,2 ]
Wei, Wendi [1 ,2 ]
Zhan, Xinli [1 ,2 ]
Liu, Chong [1 ,2 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Spine, Nanning, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Osteopathy Ward, Nanning, Peoples R China
[3] Southern Cent Hosp Yunnan Prov, Peoples Hosp Honghe State 1, Dept Spinal Surg, Luzhou, Yunnan, Peoples R China
关键词
Inflammatory cytokines; Inflammatory arthritis; Mendelian randomization; GWAS; Bidirectional; COLONY-STIMULATING FACTOR; PSORIATIC-ARTHRITIS; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; SERUM; ANGIOGENESIS; EXPRESSION; DISEASE; TISSUE;
D O I
10.1016/j.cyto.2023.156446
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objectives: Previous studies have reported an association between inflammatory cytokines and inflammatory arthritis, including Ankylosing spondylitis (AS), rheumatoid arthritis (RA), and psoriatic arthritis (PsA). This study aims to explore the causal relationship between inflammatory cytokines and AS, RA, and PsA using Mendelian randomization (MR).Methods: We conducted a bidirectional two-sample MR analysis using genetic summary data from a publicly available genome-wide association study (GWAS) that included 41 genetic variations of inflammatory cytokines, as well as genetic variant data for AS, RA, and PsA from the FinnGen consortium. The main analysis method used was Inverse variance weighted (IVW) to investigate the causal relationship between exposure and outcome. Additionally, other methods such as MR Egger, weighted median (WM), simple mode, and weighted mode were employed to strengthen the final results. Sensitivity analysis was also performed to ensure the reliability of the findings.Results: The results showed that macrophage colony-stimulating factor (MCSF) was associated with an increased risk of AS (OR = 1.163, 95 % CI = 1.016-1.33, p = 0.028). Conversely, high levels of TRAIL and beta nerve growth factor (beta-NGF) were associated with a decreased risk of AS (OR = 0.892, 95 % CI = 0.81-0.982, p = 0.002; OR = 0.829, 95 % CI = 0.696-0.988, p = 0.036). Four inflammatory cytokines were found to be asso-ciated with an increased risk of PsA: vascular endothelial growth factor (VEGF) (OR = 1.161, 95 % CI = 1.057-1.275, p = 0.002); Interleukin 12p70 (IL12p70) (OR = 1.189, 95 % CI = 1.049-1.346, p = 0.007); IL10 (OR = 1.216, 95 % CI = 1.024-1.444, p = 0.026); IL13 (OR = 1.159, 95 % CI = 1.05-1.28, p = 0.004). Interleukin 1 receptor antagonist (IL-1r alpha) was associated with an increased risk of seropositive RA (OR = 1.181, 95 % CI = 1.044-1.336, p = 0.008). Similarly, genetic susceptibility to inflammatory arthritis was found to be causally associated with multiple inflammatory cytokines. Lastly, the sensitivity analysis supported the robust-ness of these findings.Conclusions: This study provides additional insights into the relationship between inflammatory cytokines and inflammatory arthritis, and may offer new clues for the etiology, diagnosis, and treatment of inflammatory arthritis.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Causal relationships between systemic inflammatory cytokines and adhesive capsulitis: a bidirectional Mendelian randomization study
    Ouyang, Yi
    Dai, Miaomiao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Causal relationship between inflammatory factors and gynecological cancer: a Bayesian Mendelian randomization study
    Dang, Chunxiao
    Liu, Mengmeng
    Liu, Pengfei
    Liu, Jinxing
    Yu, Xiao
    Dong, Yan
    Zhao, Junde
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [23] Causal relationship between circulating inflammatory cytokines and the risk of hernia: a bidirectional Mendelian randomization study
    Qi, Yaqin
    Li, Changjiu
    Gao, Xingyue
    Zhang, Fangjie
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2025, 53 (02)
  • [24] Exploring causal correlations between inflammatory cytokines and colorectal cancer: A 2-sample Mendelian randomization study
    Zhou, Heran
    Yang, Xuefei
    Yang, Qujia
    Cai, Zelin
    Hu, Keke
    Huang, Ting
    MEDICINE, 2024, 103 (44) : e40230
  • [25] Causal Relationship Between Circulating Inflammatory Cytokines and the Risk of Trigeminal Neuralgia: A Mendelian Randomization Study
    Shang, Hui
    Liu, Xianqiang
    Bai, Mengying
    Li, Xiao
    Lan, Yuhang
    Bai, Bingbing
    Yang, Shuyun
    Wu, Xianlin
    Li, Guocai
    BRAIN AND BEHAVIOR, 2025, 15 (04):
  • [26] Exploration of the causal relationship between inflammatory cytokines and prostate carcinoma: a comprehensive Mendelian randomization study
    Cai, Xianfu
    Wang, Decai
    Ding, Chenguang
    Li, Yang
    Zheng, Jin
    Xue, Wujun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Exploring causal association between circulating inflammatory cytokines and functional outcomes following ischemic stroke: A bidirectional Mendelian randomization study
    Liu, Huacong
    Liu, Zhaoxing
    Huang, Yumeng
    Ding, Qian
    Lai, Zhenyi
    Cai, Xiaowen
    Huang, Shengtao
    Yin, Lianjun
    Zheng, Xiaoyan
    Huang, Yong
    Chen, Junqi
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (02)
  • [28] Causal relationship between inflammatory cytokines and posttraumatic stress disorder: a Mendelian randomization study and potential mechanism analysis
    Li, Yingchong
    Xu, Bangliang
    Chen, Zhitao
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2025, 16 (01)
  • [29] Exploring causal correlations between inflammatory cytokines and intervertebral disc degeneration: A Mendelian randomization
    Xu, Tao
    Chen, Guangzi
    Li, Jian
    Zhang, Yingchi
    JOR SPINE, 2024, 7 (03):
  • [30] The causal relationship between rheumatoid arthritis and bronchiectasis: a bidirectional Mendelian randomization study
    Li, Yuanyuan
    Wang, Weina
    Zhou, Dengfeng
    Li, Lili
    FRONTIERS IN MEDICINE, 2024, 11